utah.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): November 4, 2014
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
|
UTAH
|
87-0342734
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
On November 4, 2014, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend. A dividend of $.255 per share is payable on December 30, 2014 to shareholders of record at the close of business on December 16, 2014. A copy of the press release is attached hereto as Exhibit 99.1.
|
Index
|
|
|
Number
|
Description
|
| |
|
|
99.1
|
Press release issued November 4, 2014: Utah Medical Products, Inc. Increases Quarterly Dividend
|
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
UTAH MEDICAL PRODUCTS, INC.
|
| |
REGISTRANT
|
| |
|
| |
|
|
Date: 11/4/2014
|
By: /s/ Kevin L. Cornwell
|
| |
Kevin L. Cornwell
|
| |
CEO
|